These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 10634224)

  • 1. Probiotics and inflammatory bowel diseases.
    Schultz M; Sartor RB
    Am J Gastroenterol; 2000 Jan; 95(1 Suppl):S19-21. PubMed ID: 10634224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics.
    Linskens RK; Huijsdens XW; Savelkoul PH; Vandenbroucke-Grauls CM; Meuwissen SG
    Scand J Gastroenterol Suppl; 2001; (234):29-40. PubMed ID: 11768558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Manipulation of intestinal microbial flora for therapeutic benefit in inflammatory bowel diseases: review of clinical trials of probiotics, pre-biotics and synbiotics.
    Heilpern D; Szilagyi A
    Rev Recent Clin Trials; 2008 Sep; 3(3):167-84. PubMed ID: 18782075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probiotics: do they help to control intestinal inflammation?
    Böhm SK; Kruis W
    Ann N Y Acad Sci; 2006 Aug; 1072():339-50. PubMed ID: 17057214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical usefulness of probiotics in inflammatory bowel diseases.
    Mach T
    J Physiol Pharmacol; 2006 Nov; 57 Suppl 9():23-33. PubMed ID: 17242485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of intestinal flora in inflammatory bowel disease and probiotics place in their management].
    Belkahla N; Maamouri N; Ouerghi H; Ben Ammar A
    Tunis Med; 2005 Mar; 83(3):132-6. PubMed ID: 15929439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pouchitis, chronic inflammatory bowel diseases, irritable colon. To prevent with a bacteria-cocktail?].
    MMW Fortschr Med; 2003 Nov; 145(46):49. PubMed ID: 14699836
    [No Abstract]   [Full Text] [Related]  

  • 8. Probiotics in inflammatory bowel disease: possible mechanisms of action.
    Dotan I; Rachmilewitz D
    Curr Opin Gastroenterol; 2005 Jul; 21(4):426-30. PubMed ID: 15930982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of bacteria in experimental colitis.
    Guarner F; Malagelada JR
    Best Pract Res Clin Gastroenterol; 2003 Oct; 17(5):793-804. PubMed ID: 14507589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probiotics in inflammatory bowel disease: a critical review.
    Tamboli CP; Caucheteux C; Cortot A; Colombel JF; Desreumaux P
    Best Pract Res Clin Gastroenterol; 2003 Oct; 17(5):805-20. PubMed ID: 14507590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probiotics in inflammatory bowel disease: new insight to pathogenesis or a possible therapeutic alternative?
    Campieri M; Gionchetti P
    Gastroenterology; 1999 May; 116(5):1246-9. PubMed ID: 10220518
    [No Abstract]   [Full Text] [Related]  

  • 12. Probiotics and inflammatory bowel disease.
    Kwon J; Farrell R
    BioDrugs; 2003; 17(3):179-86. PubMed ID: 12749754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiota and inflammatory bowel disease.
    Hammer HF
    Dig Dis; 2011; 29(6):550-3. PubMed ID: 22179210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Probiotics for inflammatory bowel disease].
    Iizuka H; Takaishi H; Hibi T
    Nihon Rinsho; 2005 May; 63(5):776-80. PubMed ID: 15881169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probiotics: from myth to reality. Demonstration of functionality in animal models of disease and in human clinical trials.
    Dunne C; Murphy L; Flynn S; O'Mahony L; O'Halloran S; Feeney M; Morrissey D; Thornton G; Fitzgerald G; Daly C; Kiely B; Quigley EM; O'Sullivan GC; Shanahan F; Collins JK
    Antonie Van Leeuwenhoek; 1999; 76(1-4):279-92. PubMed ID: 10532384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotics and probiotics in treatment of inflammatory bowel disease.
    Gionchetti P; Rizzello F; Lammers KM; Morselli C; Sollazzi L; Davies S; Tambasco R; Calabrese C; Campieri M
    World J Gastroenterol; 2006 Jun; 12(21):3306-13. PubMed ID: 16733845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probiotics in gastroenterology: indications and future perspectives.
    Goossens D; Jonkers D; Stobberingh E; van den Bogaard A; Russel M; Stockbrügger R
    Scand J Gastroenterol Suppl; 2003; (239):15-23. PubMed ID: 14743878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probiotics and inflammatory bowel disease: from fads and fantasy to facts and future.
    Shanahan F
    Br J Nutr; 2002 Sep; 88 Suppl 1():S5-9. PubMed ID: 12215176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probiotics and the management of inflammatory bowel disease.
    Fedorak RN; Madsen KL
    Inflamm Bowel Dis; 2004 May; 10(3):286-99. PubMed ID: 15290926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics.
    Sartor RB
    Gastroenterology; 2004 May; 126(6):1620-33. PubMed ID: 15168372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.